CGP-79807

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: 98%

Keywords

CGP-79807 3-((9-ethyl-2-((trans-4-hydroxycyclohexyl)amino)-9H-purin-6-yl)amino)-Benzonitrile

Quick Details

Appearance:Powder
Application:CGP-79807 is a potent CDC2 protein kinase inhibitor that originated by Novartis. In Sep 2000, Preclinical development for Cancer in Switzerland was on-going, but no development has been reported.
PackAge:inquiry
ProductionCapacity:
Storage:-20°C Freezer
Transportation:inquiry

Superiority:

BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.

Details:

Cancer

View All

Visit Store

AT 7519 mesylate

CAS NO:902135-89-1
PD 0332991 hydrochloride

CAS NO:571189-11-2
CaSR antagonist 18c

CAS NO:802916-30-9
(R)-(+)-SLV 319

CAS NO:656827-86-0
KN 93

CAS NO:1188890-40-5
Syntide 2

CAS NO:108334-68-5

CGP-79807

CGP-79807

Keywords

Quick Details

Superiority:

Details:

You Might Also Like

AT 7519 mesylate

PD 0332991 hydrochloride

CaSR antagonist 18c

(R)-(+)-SLV 319

KN 93

Syntide 2

Related Searches

OK Cancel

CGP-79807

CGP-79807

Keywords

Quick Details

Superiority:

Details:

You Might Also Like

AT 7519 mesylate

PD 0332991 hydrochloride

CaSR antagonist 18c

(R)-(+)-SLV 319

KN 93

Syntide 2

Related Searches

OKCancel

OK Cancel